Patent intelligence · US
US 7226937
Methods for modulating phototoxicity
Methods for modulating phototoxicity
Patent details — US 7226937
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 5, 2007
- Expiration
- May 31, 2027
- Applicant
- Board of Regents, University of Arizona
- Claims
- 7
- CPC classes
- A61K, A61K2800/57, A61K31/401, A61K31/44
Quick answer
US 7226937 (Methods for modulating phototoxicity) is held by Board of Regents, University of Arizona. Status: granted. Granted Jun 5, 2007. Expires May 31, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Board of Regents, University of Arizona
- Grant date
- Expiration
- Claims
- 7
- CPC classes
- A61K, A61K2800/57, A61K31/401, A61K31/44, A61K8/4913, A61K8/4926
More from Board of Regents, University of Arizona
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 7226937?
US 7226937 (Methods for modulating phototoxicity) is held by Board of Regents, University of Arizona. Status: granted. Granted Jun 5, 2007. Expires May 31, 2027 (1 year remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7226937?
Board of Regents, University of Arizona is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 7226937 expire?
Our index shows an expiration date of May 31, 2027 (1 year from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.